A new study led by investigators at the Mass General Brigham Cancer Institute finds that a highly sensitive blood test called HPV-DeepSeq can help identify which people with HPV-associated head and neck cancer still have cancer cells in their bodies after surgery and who might benefit most from additional treatment. The results are published in Science Translational Medicine.
Please follow and like us:
